In the age of Omicron variant: Paxlovid raises new hopes of COVID‐19 recovery-Reference-Cited by-同舟云学术

In the age of Omicron variant: Paxlovid raises new hopes of COVID‐19 recovery

Published:2021-12-29 Issue: Volume: Page:
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Wang Zhonglei¹²^ORCID,Yang Liyan³^ORCID

Affiliation:

1. Key Laboratory of Green Natural Products and Pharmaceutical Intermediates in Colleges and Universities of Shandong Province, School of Chemistry and Chemical Engineering Qufu Normal University Qufu China

2. School of Pharmaceutical Sciences Tsinghua University Beijing China

3. School of Physics and Physical Engineering Qufu Normal University Qufu China

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27540

Reference19 articles.

1. https://covid19.who.int/. Assessed December 15 2021.

2. Broad‐spectrum prodrugs with anti‐SARS‐CoV‐2 activities: strategies, benefits, and challenges;Wang Z;J Med Virol,2021

3. Daily briefing: Omicron coronavirus variant puts scientists on alert

4. Omicron variant (B.1.1.529) of SARS‐CoV‐2, a global urgent public health alert!

5. Omicron potential under close scrutiny;Brits E;Nature,2021

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiviral therapy for COVID-19 virus: A narrative review and bibliometric analysis;The American Journal of Emergency Medicine;2024-11

2. De novo design of covalent bonding peptides for target protein;hLife;2024-07

3. Incorporation of eggshell waste in the preparation of carbon quantum dot nanoprobes for the determination of COVID-19 antiviral drug; molnupiravir;Microchemical Journal;2024-05

4. Safety and efficacy of Paxlovid in the treatment of adults with mild to moderate COVID-19 during the omicron epidemic: a multicentre study from China;Expert Review of Anti-infective Therapy;2024-02

5. Design, synthesis and biological evaluation of biaryl amide derivatives against SARS-CoV-2 with dual-target mechanism;European Journal of Medicinal Chemistry;2024-01